Glycans and glycoproteins as specific biomarkers for cancer

Muchena J. Kailemia, Dayoung Park, Carlito B Lebrilla

Research output: Contribution to journalArticlepeer-review

191 Scopus citations


Protein glycosylation and other post-translational modifications are involved in potentially all aspects of human growth and development. Defective glycosylation has adverse effects on human physiological conditions and accompanies many chronic and infectious diseases. Altered glycosylation can occur at the onset and/or during tumor progression. Identifying these changes at early disease stages may aid in making decisions regarding treatments, as early intervention can greatly enhance survival. This review highlights some of the efforts being made to identify N- and O-glycosylation profile shifts in cancer using mass spectrometry. The analysis of single or panels of potential glycoprotein cancer markers are covered. Other emerging technologies such as global glycan release and site-specific glycosylation analysis and quantitation are also discussed. [Figure not available: see fulltext.]

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalAnalytical and Bioanalytical Chemistry
StateAccepted/In press - Sep 3 2016


  • Cancer
  • Disease biomarker
  • Glycomics
  • Glycoproteomics
  • Mass spectrometry
  • Site-specific glycosylation

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry


Dive into the research topics of 'Glycans and glycoproteins as specific biomarkers for cancer'. Together they form a unique fingerprint.

Cite this